Prev：PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation(A23220-2)
Next：PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillance(A23220-14)
